Clinical Trials

Any further development efforts for either of our product candidates is dependent on our ability to raise additional capital.

Androxal®

If you have questions about our Androxal studies, please call Repros at 800-895-6554 ext 3403.


Current recruiting locations:


Florida
Miami


Ongoing Studies

Androxal® - An Open-Label Study to Evaluate the Effect of Age upon the Pharmacokinetics of Androxal (ZA-111) (Recruitment Closed)

Purpose: To determine and compare the pharmacokinetics (PK) of 3 doses of 25 mg Androxal in elderly healthy adult male subjects


Androxal® - Assess the Effects on Bone Mineral Density (ZA-303) (Recruitment Closed)

Purpose: To determine the effects of 12 months of treatment with Androxal on Bone Mineral Density in men with secondary Hypogonadism.


Androxal® - Head to Head Study of Androxal® Versus the Leading Topical Testosterone Gel (ZA-304) (Recruitment Closed)

Purpose: To Compare Changes in Testosterone and Sperm Concentration Following Treatment with 12.5 mg or 25 mg Androxal, Placebo, or AndroGel 1.62%


Androxal® - Head to Head Study of Androxal® Versus the Leading Topical Testosterone Gel (ZA-305) (Recruitment Closed)

Purpose: To Compare Changes in Testosterone and Sperm Concentration Following Treatment with 12.5 mg or 25 mg Androxal, Placebo, or AndroGel 1.62%



Proellex®

If you are interested in participating, and want to know if you may qualify, please call 800-895-6554 ext 3401.


Current recruiting locations:


Arkansas
Little Rock

Florida
Clearwater
Margate
South Carolina
Summerville

Texas
Houston
Utah
Riverton
Salt Lake City

Virgina
Richmond

Ongoing Studies

Proellex® - Treatment of Pre-Menopausal Women with Confirmed, Symptomatic Endometriosis (ZPE-202) (Currently recruiting)

Purpose: To determine the safety and efficacy of two doses of Proellex in premenopausal women with pelvic pain in endometriosis confirmed within the last seven years and using prescription analgesics for symptomatic pain.

2408 Timberloch Place, B-7
The Woodlands, Texas 77380
281-719-3400
281-719-3446 fax